Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
EBIATShares Issued
Ratios

Cogent Biosciences (COGT) Shares Outstanding (2017 - 2021)

Cogent Biosciences has reported Shares Outstanding over the past 5 years, most recently at $103289.0 for Q3 2021.

  • Quarterly results put Shares Outstanding at $103289.0 for Q3 2021, down 99.03% from a year ago — trailing twelve months through Sep 2021 was $103289.0 (down 99.03% YoY), and the annual figure for FY2020 was $32.3 million, up 321.98%.
  • Shares Outstanding for Q3 2021 was $103289.0 at Cogent Biosciences, down from $39.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding for COGT hit a ceiling of $39.8 million in Q2 2021 and a floor of $103289.0 in Q3 2021.
  • Median Shares Outstanding over the past 5 years was $9.2 million (2020), compared with a mean of $17.2 million.
  • Peak annual rise in Shares Outstanding hit 411.27% in 2021, while the deepest fall reached 99.03% in 2021.
  • Cogent Biosciences' Shares Outstanding stood at $20.8 million in 2017, then plummeted by 63.82% to $7.5 million in 2018, then grew by 2.01% to $7.7 million in 2019, then skyrocketed by 321.98% to $32.3 million in 2020, then crashed by 99.68% to $103289.0 in 2021.
  • The last three reported values for Shares Outstanding were $103289.0 (Q3 2021), $39.8 million (Q2 2021), and $113835.0 (Q1 2021) per Business Quant data.